Upstream Bio, Inc. (UPB)
5.34
+0.03
(+0.56%)
USD |
NASDAQ |
Sep 18, 16:00
5.35
+0.01
(+0.19%)
After-Hours: 20:00
Upstream Bio Free Cash Flow : -136.46M for June 30, 2026
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| June 30, 2026 | -136.46M |
| March 31, 2026 | -140.13M |
| Date | Value |
|---|---|
| December 31, 2025 | -133.44M |
| September 30, 2025 | -122.55M |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Sutro Biopharma, Inc. | -145.62M |
| Compass Therapeutics, Inc. | -56.38M |
| ACADIA Pharmaceuticals, Inc. | 145.62M |
| Alnylam Pharmaceuticals, Inc. | 793.94M |
| Anika Therapeutics, Inc. | 0.562M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -35.62M |
| Cash from Investing (Quarterly) | 15.76M |
| Cash from Financing (Quarterly) | 2.533M |
| Free Cash Flow Per Share (Quarterly) | -0.6528 |
| Free Cash Flow to Equity (Quarterly) | -35.46M |
| Free Cash Flow to Firm (Quarterly) | -35.62M |
| Free Cash Flow Yield | -47.09% |